Lv51
828 积分 2024-10-09 加入
Why obesity is a disease - Pathogenesis and diagnosis
17天前
已完结
Hepatic TORC2 Signaling Facilitates Acute Glucagon-Receptor Enhancement of Insulin-Stimulated Glucose Homeostasis in Mice
21天前
已完结
Survodutide Once Weekly for the Treatment of Adults with Obesity
22天前
已完结
The metabolic triad of non‐alcoholic fatty liver disease, visceral adiposity and type 2 diabetes: Implications for treatment
22天前
已完结
Survodutide Once Weekly for the Treatment of Adults with Obesity
23天前
已关闭
Role of beta-cell dysfunction, ectopic fat accumulation and insulin resistance in the pathogenesis of type 2 diabetes mellitus
23天前
已完结
Oxyntomodulin: a potential hormone from the distal gut. Pharmacokinetics and effects on gastric acid and insulin secretion in man
24天前
已完结
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial
24天前
已完结
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial
24天前
已完结
Recent progress in the pharmacotherapy for obesity
24天前
已完结
皖公网安备34019202002308
